High‐mobility group box 1 as a surrogate prognostic marker in dogs with systemic inflammatory response syndrome

Abstract

Increases in plasma HMGB1 concentration and the ratio of HMGB1 to IL-10 may predict poorer outcomes in dogs with SIRS. The approach described may lead to reliable prognostic biomarkers and new therapeutic concepts in the study of SIRS in dogs.